Status:
COMPLETED
A Clinical Study on Yasmin® vs. Marvelon® in Chinese Women Requiring Contraception
Lead Sponsor:
Bayer
Conditions:
Contraception
Eligibility:
FEMALE
20-35 years
Phase:
PHASE3
Brief Summary
The purpose of this study is to evaluate the effectiveness in terms of prevention of pregnancy and safety of the oral contraceptive Yasmin and Marvelon on cycle control in healthy Chinese women
Detailed Description
The study has previously been posted by Schering AG, Germany. Schering AG, Germany has been renamed to Bayer Schering Pharma AG, Germany. Bayer Schering Pharma AG, Germany is the sponsor of the trial...
Eligibility Criteria
Inclusion
- Healthy Chinese female requesting contraceptives
Exclusion
- Vascular, metabolic, hepatic, renal, oncologic and other diseases
Key Trial Info
Start Date :
November 1 2003
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2006
Estimated Enrollment :
842 Patients enrolled
Trial Details
Trial ID
NCT00185419
Start Date
November 1 2003
End Date
March 1 2006
Last Update
January 14 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ask Contact, China